Suan Farma
Suan Farma, a prominent player in the pharmaceutical and biotechnology industry, is headquartered in the United States, with significant operations across Europe and Latin America. Founded in 2000, the company has established itself as a leader in the development and manufacturing of high-quality active pharmaceutical ingredients (APIs) and finished dosage forms. Suan Farma's core offerings include a diverse range of products tailored for various therapeutic areas, distinguished by their commitment to innovation and regulatory compliance. The company has achieved notable milestones, including strategic partnerships and expansions that enhance its market position. With a focus on sustainability and quality, Suan Farma continues to make significant contributions to the global healthcare landscape, reinforcing its reputation as a trusted provider in the pharmaceutical sector.
DitchCarbon Score
How does Suan Farma's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Metal Fabrication industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Suan Farma's score of 17 is higher than 89% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Suan Farma's reported carbon emissions
In 2023, Suan Farma reported total emissions of approximately 11,450,770 kg CO2e, with Scope 1 emissions at about 490,206 kg CO2e and Scope 2 emissions at approximately 11,453,570 kg CO2e. The following year, 2024, emissions slightly decreased, with Scope 1 emissions at around 451,010 kg CO2e and Scope 2 emissions at about 10,995,310 kg CO2e. In 2021, the company had significantly higher total emissions of approximately 180,295,600 kg CO2e, comprising about 76,702,500 kg CO2e from Scope 1, 506,000 kg CO2e from Scope 2, and a substantial 181,115,200 kg CO2e from Scope 3 emissions. Despite these figures, Suan Farma has not disclosed any specific reduction targets or initiatives as part of their climate commitments. The absence of documented reduction strategies suggests a need for further development in their sustainability efforts.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2021 | 2023 | 2024 | |
|---|---|---|---|
| Scope 1 | 76,702,500 | 000,000 | 000,000 |
| Scope 2 | 506,000 | 00,000,000 | 00,000,000 |
| Scope 3 | 181,115,200 | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Suan Farma is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
